DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer

Shunichiro Makino, Hidekazu Takahashi, Daisuke Okuzaki, Norikatsu Miyoshi, Naotsugu Haraguchi, Taishi Hata, Chu Matsuda, Hirofumi Yamamoto, Tsunekazu Mizushima, Masaki Mori, Yuichiro Doki

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)394-396
Number of pages3
JournalCarcinogenesis
Volume41
Issue number3
DOIs
Publication statusPublished - May 14 2020

All Science Journal Classification (ASJC) codes

  • Cancer Research

Cite this

Makino, S., Takahashi, H., Okuzaki, D., Miyoshi, N., Haraguchi, N., Hata, T., Matsuda, C., Yamamoto, H., Mizushima, T., Mori, M., & Doki, Y. (2020). DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer. Carcinogenesis, 41(3), 394-396. https://doi.org/10.1093/carcin/bgaa016